Publication | Open Access

Safety and outcome after thrombolytic treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use

ThrombosisIschemic Stroke PatientsVenous ThrombosisIschemic StrokeCardiovascular DiseaseMedicinePatient SafetyThrombolytic TreatmentStroke-related ConditionNeurologyHigh-risk Cardioembolic SourcesCerebral Blood FlowPlatelet AntagonistStrokeAnticoagulantIschemic Syndrome